南山智尚(300918.SZ):公司的抗病毒面料技術是利用先進的銀離子結合脂質體囊泡技術
格隆匯12月6日丨南山智尚(300918.SZ)近期在接待機構投資者調研時表示,南山智尚公司的抗病毒面料技術是利用先進的銀離子結合脂質體囊泡技術。銀離子因其廣譜的抗菌特性而被廣泛認可,能有效對付多種細菌、真菌以及包膜病毒。該技術通過長效釋放銀離子,不僅能夠在初次接觸時消滅病原體,還能提供持久的保護作用。這對於希望減少交叉感染風險的消費者而言,具有極大的吸引力。在市場客户方面,南山智尚的抗菌、抗病毒面料已成功打入日本、韓國、俄羅斯等外貿市場。這些地區對高質量、功能性紡織品的需求較大,顯示出公司產品的國際競爭力。同時,公司在內貿市場也表現積極,主要向戰略合作客户銷售抗菌面料。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.